Total Payments
$1,619
2024 Payments
$286.72
Companies
10
Transactions
22
Medicare Patients
2,683
Medicare Billing
$522,242
Payment Breakdown by Category
Food & Beverage$1,490 (92.0%)
Education$128.98 (8.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,490 | 19 | 92.0% |
| Education | $128.98 | 3 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $543.53 | 6 | $0 (2018) |
| Gilead Sciences, Inc. | $302.48 | 4 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $136.06 | 2 | $0 (2024) |
| The Medicines Company | $123.69 | 1 | $0 (2017) |
| ABBVIE INC. | $120.46 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $119.79 | 1 | $0 (2018) |
| Janssen Products, LP | $101.99 | 2 | $0 (2018) |
| Astellas Pharma US Inc | $89.99 | 1 | $0 (2017) |
| Philips North America LLC | $42.20 | 2 | $0 (2024) |
| Melinta Therapeutics, LLC | $38.68 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $286.72 | 4 | Paratek Pharmaceuticals, Inc. ($124.06) |
| 2023 | $100.85 | 1 | Gilead Sciences, Inc. ($100.85) |
| 2022 | $18.83 | 1 | Melinta Therapeutics, LLC ($18.83) |
| 2021 | $19.85 | 1 | Melinta Therapeutics, LLC ($19.85) |
| 2019 | $12.00 | 1 | Paratek Pharmaceuticals, Inc. ($12.00) |
| 2018 | $431.82 | 5 | Gilead Sciences, Inc. ($178.87) |
| 2017 | $748.80 | 9 | Allergan Inc. ($437.36) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $22.34 | General |
| Category: Medical Device | ||||||
| 08/29/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Medical Device | ||||||
| 07/31/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.06 | General |
| Category: ANTIBIOTIC | ||||||
| 05/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $120.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/24/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $100.85 | General |
| 08/04/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: ANTIBIOTICS | ||||||
| 10/07/2021 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: ANTIBIOTICS | ||||||
| 10/31/2019 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: ANTIBIOTIC | ||||||
| 12/19/2018 | Janssen Products, LP | PREZCOBIX (Drug) | Education | In-kind items and services | $26.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/17/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $94.39 | General |
| 06/07/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $106.17 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/15/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Food and Beverage | In-kind items and services | $119.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/27/2018 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $84.48 | General |
| Category: HIV | ||||||
| 11/09/2017 | Janssen Products, LP | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 10/19/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/05/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $22.76 | General |
| 10/03/2017 | The Medicines Company | VABOMERE (Drug) | Food and Beverage | In-kind items and services | $123.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/26/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $111.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $124.78 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/23/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 06/07/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/13/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $125.27 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 603 | 1,223 | $462,928 | $122,634 |
| 2022 | 8 | 702 | 1,433 | $498,191 | $129,667 |
| 2021 | 8 | 711 | 1,451 | $502,645 | $133,145 |
| 2020 | 7 | 667 | 1,630 | $520,495 | $136,796 |
Total Patients
2,683
Total Services
5,737
Medicare Billing
$522,242
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 162 | 469 | $166,261 | $47,800 | 28.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 180 | 222 | $138,057 | $32,464 | 23.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 136 | 363 | $86,877 | $24,395 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 80 | $34,004 | $8,466 | 24.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 35 | $20,866 | $4,916 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $16,494 | $4,391 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 24 | $369.00 | $201.60 | 54.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 163 | 599 | $197,427 | $51,860 | 26.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 187 | 216 | $93,876 | $24,111 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 158 | 373 | $85,831 | $22,560 | 26.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 69 | 74 | $47,190 | $12,405 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 94 | $40,318 | $10,293 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 40 | $23,960 | $5,878 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $9,409 | $2,501 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 20 | $180.00 | $59.16 | 32.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 203 | 692 | $232,427 | $61,713 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 165 | 366 | $85,431 | $22,534 | 26.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 172 | 191 | $84,308 | $21,752 | 25.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 70 | 75 | $48,745 | $12,988 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 48 | 70 | $27,858 | $7,723 | 27.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $14,314 | $3,870 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 20 | $5,550 | $1,558 | 28.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $4,012 | $1,006 | 25.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 141 | 525 | $176,925 | $47,293 | 26.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 209 | 727 | $171,572 | $44,917 | 26.2% |
About Dr. Benjamin Bluen, M.D
Dr. Benjamin Bluen, M.D is a Infectious Disease healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1487093373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Bluen, M.D has received a total of $1,619 in payments from pharmaceutical and medical device companies, with $286.72 received in 2024. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,490).
As a Medicare-enrolled provider, Bluen has provided services to 2,683 Medicare beneficiaries, totaling 5,737 services with total Medicare billing of $522,242. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Internal Medicine, Infectious Disease
- Location Richmond, VA
- Active Since 06/24/2013
- Last Updated 01/24/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487093373
Products in Payments
- AVYCAZ (Drug) $432.15
- DALVANCE (Drug) $231.84
- NUZYRA (Drug) $136.06
- VABOMERE (Drug) $123.69
- ISENTRESS (Drug) $119.79
- Biktarvy (Drug) $84.48
- (CK6) Holter (Device) $42.20
- Kimyrsa (Drug) $38.68
- PREZCOBIX (Drug) $26.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Richmond
Mr. Barnett Gibbs, M.d., Facc, M.D., FACC
Infectious Disease — Payments: $5,301
Infectious Disease $5,301
Dr. George Vail, M.d, M.D
Infectious Disease — Payments: $1,351
Infectious Disease $1,351
Julie Boatman, Do, DO
Infectious Disease — Payments: $706.52
Infectious Disease $706.52
Julie Reznicek, D.o, D.O
Infectious Disease — Payments: $625.00
Infectious Disease $625.00
Nicole Vissichelli, Md, MD
Infectious Disease — Payments: $468.08
Infectious Disease $468.08
David Rowles, Md, MD
Infectious Disease — Payments: $414.12
Infectious Disease $414.12